The PD/L-1 Inhibitors Market  has been experiencing rapid growth, driven by advancements in immunotherapy and the rising global cancer burden. PD-1 and PD-L1 inhibitors are revolutionizing cancer treatments by using the immune system to target and eliminate cancer cells. As the number of clinical trials and regulatory approvals increases, the PD/L-1 Inhibitors Treatment Market is expected...